Literature DB >> 10447708

B-cell responses to a peptide epitope: mutations in heavy chain alone lead to maturation of antibody responses.

R Tuteja1.   

Abstract

In the present study, the genetic mechanisms responsible for generation of antibodies recognizing the dominant epitope within a synthetic peptide PS1CT3 were examined. PS1CT3 is a peptide model antigen containing residues 28-42 of the large protein of the surface antigen of hepatitis B virus as B epitope (designated PS1), and the known T-helper-cell epitope derived from the circumsporozoite protein of the malaria parasite Plasmodium falciparum (designated CT3). To characterize the repertoire generated, the immunoglobulin heavy chain variable regions from IgM and IgG monoclonal antibodies against PS1CT3 were sequenced. Although all IgG monoclonal antibodies were directed against the immunodominant epitope, the genetic elements used were diverse. Comparison of the sequence of germ line precursor IgM to a mature IgG revealed that during maturation of the primary IgM response only the heavy chain fragment of the antibody molecule underwent somatic mutation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447708      PMCID: PMC2326809          DOI: 10.1046/j.1365-2567.1999.00743.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  Diverse VH and VL genes are used to produce antibodies against a defined protein epitope.

Authors:  M L Andria; S Levy; E Benjamini
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

Review 2.  Conformations of immunoglobulin hypervariable regions.

Authors:  C Chothia; A M Lesk; A Tramontano; M Levitt; S J Smith-Gill; G Air; S Sheriff; E A Padlan; D Davies; W R Tulip
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

3.  B cell responses to a peptide epitope. V. Kinetic regulation of repertoire discrimination and antibody optimization for epitope.

Authors:  B P Nayak; R Tuteja; V Manivel; R P Roy; R A Vishwakarma; K V Rao
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

4.  Cloning of the immunological repertoire in Escherichia coli for generation of monoclonal catalytic antibodies: construction of a heavy chain variable region-specific cDNA library.

Authors:  L Sastry; M Alting-Mees; W D Huse; J M Short; J A Sorge; B N Hay; K D Janda; S J Benkovic; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Nucleotide changes in sequential variants of influenza virus hemagglutinin genes and molecular structures of corresponding monoclonal antibodies specific for each variant.

Authors:  K Meek; B Johansson; J Schulman; C Bona; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Chemistry of antibody binding to a protein.

Authors:  H M Geysen; J A Tainer; S J Rodda; T J Mason; H Alexander; E D Getzoff; R A Lerner
Journal:  Science       Date:  1987-03-06       Impact factor: 47.728

7.  The BALB/c secondary response to the Sb site of influenza virus hemagglutinin. Nonrandom silent mutation and unequal numbers of VH and Vk mutations.

Authors:  S Clarke; R Rickert; M K Wloch; L Staudt; W Gerhard; M Weigert
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

8.  Two murine natural polyreactive autoantibodies are encoded by nonmutated germ-line genes.

Authors:  R Baccala; T V Quang; M Gilbert; T Ternynck; S Avrameas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

9.  Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin.

Authors:  S H Clarke; K Huppi; D Ruezinsky; L Staudt; W Gerhard; M Weigert
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

10.  Antibodies that are specific for a single amino acid interchange in a protein epitope use structurally distinct variable regions.

Authors:  S E Stark; A J Caton
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  3 in total

1.  Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity.

Authors:  Elena Gabrielli; Eva Pericolini; Elio Cenci; Federica Ortelli; Walter Magliani; Tecla Ciociola; Francesco Bistoni; Stefania Conti; Anna Vecchiarelli; Luciano Polonelli
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

2.  Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities.

Authors:  Luciano Polonelli; José Pontón; Natalia Elguezabal; María Dolores Moragues; Claudio Casoli; Elisabetta Pilotti; Paola Ronzi; Andrey S Dobroff; Elaine G Rodrigues; Maria A Juliano; Domenico Leonardo Maffei; Walter Magliani; Stefania Conti; Luiz R Travassos
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240

3.  In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity.

Authors:  Sapna Pahil; Neelam Taneja; Hifzur Rahman Ansari; G P S Raghava
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.